期刊文献+

Interaction of 1,2-Diaminoimidazoles with Ethoxymythelene-Containing Compounds

Interaction of 1,2-Diaminoimidazoles with Ethoxymythelene-Containing Compounds
下载PDF
导出
机构地区 Faculty of Chemistry
出处 《材料科学与工程(中英文B版)》 2015年第7期288-292,共5页 Journal of Materials Science and Engineering B
关键词 化合物 氰乙酸乙酯 二氧六环 二甲基甲酰胺 线性相关 反应条件 区域选择性 相互作用 1, 2-diamino-4-phenylimidazole, ethoxymethylenemalondinitrile, ethoxymythelenecyanoacetic ester,ethoxymethyleneacetylacetone, ethoxylacetoacetic ester, imidazopyridazines.
  • 相关文献

参考文献16

  • 1Zhang, L., Peng, X-M., Damu, G. L. V., Geng, R-X. and Zhou, C-H. 2013. "Comprehensive Review in Current Developments of Imidazole-Based Medicinal Chemistry." Medicinal Research Reviews 34 (2): 340-437.
  • 2Huang, W-S., Metcalf, C. A., Sundaramoorthi, R., Wang, Y., Zou, D. and Thomas, R. M. et al. 2010. "Discovery of 3-[2-(Imidazo[1,2-b]Pyridazin-3 -yl)Ethynyl]-4-Methyl-N - {4-[(4-Methylpiperazin- 1 -yl)-Methyl]-3-(Trifluoromethy l)PhenylJBenzamide (AP24534), a Potent, Orally Active Pan-Inhibitor of Breakpoint Cluster Region-Abelson (BCR-ABL) Kinase Including the T315I Gatekeeper Mutant." J. Med. Chem. 53: 4701-19.
  • 3Peterson, E. A., Boezio, A. A., Andrews, P. S., Boezio, C M., Bush, T. L. and Cheng, A. C. et al. 2012. "Discovery and Optimization of Potent and Selective Imidazopyridine and Imidazopyridazine mTOR Inhibitors." Bioorganic Medicinal Chemistry Letters 22: 4967-74.
  • 4Miller, G. D., Woessner, D. W., Sirch, M. J. and Lim, C. S. 2013. "Multidomain Targeting of Bcr-Abl by Disruption of Oligomerization and Tyrosine Kinase Inhibition: Toward Eradication of CML." Mol. Pharmaceutics 10: 3475-83.
  • 5Foulks, J. M., Carpenter, K. J., Luo, B., Xu, Y., Senina, A. and Nix, R. et al. 2014. "A Small-Molecule Inhibitor of PIM Kinases as a Potential Treatment for Urothelial Carcinomas." Neoplasia i6: 403-12.
  • 6Moreau, S., Coudert, P., Rubat, C., Vallee-Goyet, D., Gardette, D. and Gramain, J-C. et al. 1998. "Synthesis and Anticonvulsant Properties of Triazolo- and Imidazopyridazinyl Carboxamides and Carboxylic Acids." Bioorganic Medicinal Chemistry 6: 983-91.
  • 7Rimoli, M. G., Russo, E., Cataldi, M., Citraro, R., Ambrosino, P. and Melisi, D. et al. 2009. "T-Type Channel Blocking Properties and Antiabsence Activity of Two Imidazo [1, 2-b] Pyridazine Derivatives Structurally Related to Indomethacin." Neuropharmacology 56: 637-46.
  • 8Chapman, T. M., Osborne, S. A., Bouloc, N., Large, J. M., Wallace, C. and Birchall, K. et al. 2013. "Substituted Imidazopyridazines are Potent and Selective Inhibitors of Plasmodium Falciparum Calcium-Dependent Protein Kinase 1 (PfCDPK1)." Bioorganic Medicinal Chemistry Letters 23: 3064-9.
  • 9Large, J. M., Osborne, S. A., Smiljanic-Hurley, E., Ansell, K. H., Jones, H. M. and Taylor, D. L. et al. 2013. "Imidazopyridazines as Potent Inhibitors of Plasmodium Falciparum Calcium-Dependent Protein Kinase 1 (PfCDPK1): Preparation and Evaluation of PyrazoleLinked Analogues." Bioorganic & Medicinal Chemistry Letters 23 (21): 6019-24.
  • 10Roberts, L. R., Bradley, P. A., Bunnage, M. E., England, K. S., Fairman, D. and Fobian, Y. M. et al. 2011. "Acidic Triazoles as Soluble Guanylate Cyclase Stimulators." Bioorganic Medicinal Chemistry Letters 21:6515-8.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部